Groundbreaking Malaria Vaccine under Test

Why in news?

  • The World Health Organisation welcomed a pilot project in Malawi of administering a malaria vaccine to children below the age of 2 years. A total 3,60,000 children across three African countries — Malawi, Ghana and Kenya — will be covered every year with the vaccine.

What is the RTS, S (Mosquirix) vaccine?

  • RTS, S/AS01 (trade name Mosquirix) is a recombinant protein-based malaria vaccine.
  • A pilot project for vaccination has been launched on April 23, 2019 in Malawi. Ghana and Kenya are to join the program later this year.
  • The vaccine has been developed by GSK (GlaxoSmithKline ) ....

Do You Want to Read More?
Subscribe Now

To get access to detailed content

Already a Member? Login here


Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material since 2018 of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.